Entry - #615909 - DIAMOND-BLACKFAN ANEMIA 13; DBA13 - OMIM
# 615909

DIAMOND-BLACKFAN ANEMIA 13; DBA13


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
14q21.3 Diamond-Blackfan anemia 13 615909 AD 3 RPS29 603633
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal dominant
HEMATOLOGY
- Normocytic anemia
NEOPLASIA
- Possibly increased risk of cancer
LABORATORY ABNORMALITIES
- Elevated erythrocyte adenosine deaminase
MISCELLANEOUS
- One family and an unrelated patient have been reported (last curated July 2014)
- Onset in childhood
- No dysmorphic features
- Most cases are responsive to steroids
- Incomplete penetrance
- Variable expressivity
MOLECULAR BASIS
- Caused by mutation in the ribosomal protein S29 gene (RPS29, 603633.0001)

TEXT

A number sign (#) is used with this entry because of evidence that Diamond-Blackfan anemia-13 (DBA13) is caused by heterozygous mutation in the RPS29 gene (603633) on chromosome 14q.

For a discussion of genetic heterogeneity of Diamond-Blackfan anemia, see DBA1 (105650).


Clinical Features

Mirabello et al. (2014) reported a 2-generation family in which 5 individuals developed Diamond-Blackfan anemia between 3 months and 9 years of age. The severity was variable: 4 patients responded to steroids and were in remission as adults, whereas the disorder was refractory to steroids in 1 patient, who underwent bone marrow transplant. None of the patients had dysmorphic features, and 1 patient who was a smoker developed lung cancer at age 56. Laboratory studies showed increased erythrocyte adenosine deaminase in most patients and in 1 asymptomatic carrier. A 25-year-old man in an unrelated family presented with DBA at age 2 years. The disorder was responsive to steroid treatment, and he was in remission from age 4 years. He did not have dysmorphic features. An asymptomatic half-sib had increased erythrocyte adenosine deaminase. Both families had several members with cancer.


Inheritance

The transmission pattern of DBA13 in the families reported by Mirabello et al. (2014) was consistent with autosomal dominant inheritance and incomplete penetrance.


Molecular Genetics

In affected members of 2 unrelated families with Diamond-Blackfan anemia, Mirabello et al. (2014) identified heterozygous missense mutations in the RPS29 gene (603633.0001 and 603633.0002). The mutations, which were found by whole-exome sequencing, segregated with the disorder in the families; however, both families showed evidence of incomplete penetrance. Functional studies showed that the mutations caused haploinsufficiency of RPS29.


REFERENCES

  1. Mirabello, L., Macari, E. R., Jessop, L., Ellis, S. R., Myers, T., Giri, N., Taylor, A. M., McGrath, K. E., Humphries, J. M., Ballew, B. J., Yeager, M., Boland, J. F., He, J., Hicks, B. D., Burdett, L., Alter, B. P., Zon, L., Savage, S. A. Whole-exome sequencing and functional studies identify RPS29 as a novel gene mutated in multicase Diamond-Blackfan anemia families. Blood 124: 24-32, 2014. [PubMed: 24829207, images, related citations] [Full Text]


Creation Date:
Cassandra L. Kniffin : 7/28/2014
carol : 04/19/2017
carol : 12/01/2016
carol : 07/29/2014
mcolton : 7/28/2014
ckniffin : 7/28/2014

# 615909

DIAMOND-BLACKFAN ANEMIA 13; DBA13


ORPHA: 124;   DO: 0111889;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
14q21.3 Diamond-Blackfan anemia 13 615909 Autosomal dominant 3 RPS29 603633

TEXT

A number sign (#) is used with this entry because of evidence that Diamond-Blackfan anemia-13 (DBA13) is caused by heterozygous mutation in the RPS29 gene (603633) on chromosome 14q.

For a discussion of genetic heterogeneity of Diamond-Blackfan anemia, see DBA1 (105650).


Clinical Features

Mirabello et al. (2014) reported a 2-generation family in which 5 individuals developed Diamond-Blackfan anemia between 3 months and 9 years of age. The severity was variable: 4 patients responded to steroids and were in remission as adults, whereas the disorder was refractory to steroids in 1 patient, who underwent bone marrow transplant. None of the patients had dysmorphic features, and 1 patient who was a smoker developed lung cancer at age 56. Laboratory studies showed increased erythrocyte adenosine deaminase in most patients and in 1 asymptomatic carrier. A 25-year-old man in an unrelated family presented with DBA at age 2 years. The disorder was responsive to steroid treatment, and he was in remission from age 4 years. He did not have dysmorphic features. An asymptomatic half-sib had increased erythrocyte adenosine deaminase. Both families had several members with cancer.


Inheritance

The transmission pattern of DBA13 in the families reported by Mirabello et al. (2014) was consistent with autosomal dominant inheritance and incomplete penetrance.


Molecular Genetics

In affected members of 2 unrelated families with Diamond-Blackfan anemia, Mirabello et al. (2014) identified heterozygous missense mutations in the RPS29 gene (603633.0001 and 603633.0002). The mutations, which were found by whole-exome sequencing, segregated with the disorder in the families; however, both families showed evidence of incomplete penetrance. Functional studies showed that the mutations caused haploinsufficiency of RPS29.


REFERENCES

  1. Mirabello, L., Macari, E. R., Jessop, L., Ellis, S. R., Myers, T., Giri, N., Taylor, A. M., McGrath, K. E., Humphries, J. M., Ballew, B. J., Yeager, M., Boland, J. F., He, J., Hicks, B. D., Burdett, L., Alter, B. P., Zon, L., Savage, S. A. Whole-exome sequencing and functional studies identify RPS29 as a novel gene mutated in multicase Diamond-Blackfan anemia families. Blood 124: 24-32, 2014. [PubMed: 24829207] [Full Text: https://doi.org/10.1182/blood-2013-11-540278]


Creation Date:
Cassandra L. Kniffin : 7/28/2014

Edit History:
carol : 04/19/2017
carol : 12/01/2016
carol : 07/29/2014
mcolton : 7/28/2014
ckniffin : 7/28/2014